Site Logo

Download QR

Open Free Demat Account!

Join Our 9 Lakh Customers

+91
Headphone

Home

Mutual Funds

ITI Pharma and Healthcare Fund

IT

ITI Pharma and Healthcare Fund

Sectoral-PharmaRank #21
1/5

NAV (2026-07-14)

17.6

AUM

₹251.87 Cr

Exp. Ratio: 2.69%

RISK LEVEL

Very High

Returns & Performance

1 Year5.86%6.97% vs cat avgRank #25
3 Year19.01%3.61% vs cat avgRank #14
5 Year----
Since Launch12.83%--

Fund vs Category Average

1Y
5.86%-6.97%
3Y
19.01%-3.61%

Pros & Cons

Pros

No lock-in period

Cons

1Y returns trail category average
3Y returns below category average
Higher expense ratio (2.69%)
1Y category rank outside top 15 (#25)
Overall rank #21 in category
ISININF00XX01BL5
NAV₹17.6
NAV Date2026-07-14
AUM₹251.87 Cr
Expense Ratio2.69%
RiskVery High
Rating1 / 5
Min SIP Amount₹500
Max SIP Amount₹999999999
Min Additional Inv.₹1000
SIP AllowedYes
Plan TypeRegular
Plan OptionGrowth
Is NFONo
Fund House Incorp.2018-05-14

INVESTMENT OBJECTIVE

The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare.

Exit Load1.00%
Stamp duty on investment0.005% (from July 1st, 2020)
Tax implicationsIf you redeem within one year, your returns will be taxed at 20%. For redemptions after one year, returns exceeding ₹1.25 lakh in a financial year will be taxed at 12.5%.

Animesh Singh

Post Graduate Diploma in Management, Bachelor of Honours -(Economics) CFA - USA Certification.

Prior to joining the ITI AMC, he was associated with Julius Baer wealth Advisor, Centrum Wealth, Nippon Life India Asset Management Ltd, Reliance Portfolio Management Services, KSBL and SSKI Securities.

Top Holdings

Holdings data not available for this scheme